Background-Aspergillus fumigatus is a pathogenic fungus which causes a range of diseases, particularly in the human lung. The pathological mechanism is unknown but may involve a complex mixture of biomolecules which can diVuse from the spore surface. This material is known as A fumigatus diVusate (AfD) and has previously been shown to have a range of immunosuppressive functions. It is hypothesised that AfD may influence the binding of spores to extracellular matrix (ECM) proteins and lung epithelial cells, thereby aVecting the ability of the fungus to cause infection. (Thorax 2000;55:579-584) 
The fungus Aspergillus fumigatus is commonly found in the environment, its usual habitat being dead or decaying organic matter. The fungus causes many human lung diseases 1 2 and a major factor in determining its pathogenicity is the size of the spores which are about 3 µm in diameter. Mullins et al 3 have shown that many more spores of A fumigatus are present in the lungs at necroscopic examination than would be anticipated from their presence in the air. The survival rate of spores of A fumigatus in rabbit lung is also greater than that of control spores of a similar size. 4 The spores therefore appear to have some survival advantage in the human lung over other spores. The exact mechanism of pathogenicity is unclear but the adhesion of spores to host tissues and, in particular, to proteins of the extracellular matrix is believed to be an essential event leading to persistence of the fungus in the lung. [5] [6] [7] Fungal spores also adhere to lung epithelial cells whereby they can be internalised and evade phagocytosis, 8 leading to destruction of the host tissue. 7 Various defence mechanisms exist to protect against spore persistence such as phagocytosis by the alveolar macrophage and, in particular, the involvement of bioactive components found in lung surfactant. This is a complex mixture of lipids and proteins which is essential for normal lung function by reducing surface tension. 9 10 Surfactant proteins A (SP-A) and D (SP-D) have been shown to enhance the uptake of bacteria 11 and A fumigatus spores 12 by phagocytic cells. SP-D seems to be particularly important as levels have been reported to increase in patients with lung injury or pathogen infection 13 while those of SP-A seem to decrease.
14 Several other factors may contribute to the pathogenicity of A fumigatus. These include gliotoxin (an immunosuppressive hyphal toxin), 15 proteases which reduce cell spreading 16 and promote detachment of cultured cells, 17 18 and an as yet uncharacterised component from the spore surface known as Aspergillus fumigatus diVusate (AfD). 19 AfD has several activities including inhibition of the spreading and chemotaxis of macrophages, 16 inhibition of the macrophage respiratory burst, 20 and inhibition of macrophage cytokine gene expression 21 and phagocytosis. 22 The components of AfD responsible for these activities are as yet unknown, but studies are ongoing in this laboratory to characterise AfD more fully. Since AfD is quickly released from the spore surface in aqueous solution 19 and, when inhaled, the spore comes into contact with lung surfactant and its components, it is possible that some of the constituents of AfD may influence the ability of spores to bind to epithelial cells and to proteins of the extracellular matrix. It is also possible that protective components within the surfactant such as SP-D may interfere with spore binding. This study was therefore undertaken to examine the eVects of AfD and SP-D enriched BAL fluid on spore binding to ECM proteins and A549 epithelial cells.
Methods

MATERIALS
In-house bred Wistar rats were used throughout. All chemicals were of the highest analytical grade available. Collagen I (calf skin), laminin (from Engelbreth-Holm-Swarm mouse sarcoma), fibronectin (human plasma), and maltose agarose were from Sigma (Poole, Dorset). Fibrinogen (human plasma) was from Calbiochem.
BRONCHOALVEOLAR LAVAGE
Rats were killed by intraperitoneal injection of sodium pentobarbitone (Euthatal; Rhone Merieux Ltd). The lungs were dissected free of the thoracic cavity and were lavaged with 4 × 8 ml sequential volumes of saline at 37°C. The bronchoalveolar lavage (BAL) fluid was concentrated either by freeze drying or by using a centrifugal microconcentrator with a cut oV molecular weight of 5 kDa (Microsep, Flowgen). This was aliquoted and stored at -30°C until required for production of SP-D enriched BAL fluid.
FUNGAL SPORES AND A FUMIGATUS DIFFUSATE
A single strain of A fumigatus was isolated from the sputum of a patient with allergic bronchopulmonary aspergillosis. Spores were obtained from cultures grown for 10 days at 30°C on malt agar. Spore suspensions were prepared in 5 mM sodium phosphate buVer pH 7.3 by gentle homogenisation. Spore counts were performed using an improved Neubauer chamber. To obtain diVusate the spores were incubated at a concentration of 10 8 /ml in Hanks' balanced salt solution (HBSS) at 37°C for one hour in an orbital incubator. Spores were removed by passing the suspension through Whatman number 1 filter paper followed by a 0.22 µm sterile filter and the soluble diVusate was stored at -20°C. To prepare spores for the binding assays a spore suspension was prepared which was incubated as above. The suspension was centrifuged at 25 000g for 30 minutes at room temperature, the supernatant was removed, and the spore pellet was resuspended in the same buVer. This was repeated a total of six times and the washed spores were used immediately in the binding assay. Alternatively, they could be stored at -30°C for at least three months without aVecting binding ability. To ensure that all the AfD components were removed by repeated washing, samples of the supernatants were routinely subjected to SDS-PAGE to monitor loss of protein. Protein was not usually detectable after three washes.
SPORE BINDING ASSAY
Laminin, fibrinogen, fibronectin, or collagen I in 200 µl phosphate buVered saline (PBS) were coated onto 96-well plates (Helena Biosciences) at concentrations up to 500 µg/ml at 4°C for 16 hours. The plates were washed three times with PBS and were blocked for one hour at 37°C with 1% w/v bovine serum albumin (BSA) in PBS. The plates were washed several times with PBS and 200 µl of spore suspension (10 6 /ml) was added. This was incubated for one hour at 37°C and washed several times with PBS. Glutaraldehyde (200 µl 10% v/v solution) was added for 15 minutes at room temperature and the spores were counted (five fields of view for each triplicate well) using a DM 1L Leica inverted phase contrast microscope at ×400 magnification.
GROWTH OF A549 EPITHELIAL CELLS AND SPORE BINDING ASSAY
Cells were grown in complete Dulbecco's modified Eagle medium (CDMEM) at 37°C in 5% v/v CO 2 for 2-3 days. They were harvested by trypsinisation and centrifugation at 3000g and resuspended in CDMEM. Cells were seeded into 96-well culture plates (Corning) at 10 5 cells/well and were grown to confluence overnight. The binding assay is an adaptation of one previously reported. 6 Briefly, after washing the plates with PBS, 200 µl of spore suspension (10 6 /ml in CDMEM) was added to each well and incubated as above for 30 minutes with gentle shaking. The plates were then washed with PBS containing 0.05% v/v Tween-20 then fixed with 2.5% v/v glutaraldehyde for 15 minutes and counted as above.
PARTIAL PURIFICATION OF SP-D
Partial purification of SP-D was carried out as previously reported by aYnity chromatography using maltose agarose. 23 The SP-D was eluted using NaCl which was then dialysed exhaustively at 4°C against PBS. This SP-D enriched fraction (SP-D enriched BAL fluid) was then concentrated using a centrifugal microconcentrator with a cut oV molecular weight of 5 kDa (Microsep, Flowgen), aliquoted, and stored at -30°C. SDS-PAGE of this material showed an intense protein band at around 43 kDa, the known molecular weight of SP-D, together with several other proteins, one of which was around 30 kDa which is characteristic of SP-A.
ENHANCEMENT OF SPORE BINDING BY AFD
This was performed as for the standard spore binding assay above except that AfD (up to 100% v/v) was added to the wells after the blocking step followed by incubation at room temperature for three hours. The plates were washed several times with PBS before incubation with spores. A control used to test the specificity of AfD was a diVusate made from spores of Aspergillus nidulans prepared as given above for AfD. 
SDS-PAGE AND PROTEIN ASSAY
Protein was assayed using the BioRad reagent and SDS-PAGE was performed by the method of Laemlli. 24 Proteins were stained using Gelcode TM silver stain (Pierce).
EXPERIMENTAL DESIGN AND STATISTICAL
ANALYSIS
All experiments were performed in triplicate at least three times (n >9) to allow for any variability in the quality of the AfD in terms of spore binding enhancement since, in a previous publication, 19 we found that the ability of AfD to inhibit the lung macrophage oxidative burst was highly variable. The data were subjected to analysis of variance with the Tukey test for significance of diVerences between treatments with p<0.05 as the level of significance. In the experimental results shown in fig 4 two way analysis of variance was done using the concentrations of lavage protein and calcium as the two factors, with p<0.05 as the level of significance.
Results
SPORE BINDING TO EXTRACELLULAR MATRIX PROTEINS AND A549 EPITHELIAL CELLS
Spores bound to both collagen I and laminin in a concentration dependent manner (fig 1) . A similar result was obtained for fibronectin and the plasma glycoprotein fibrinogen although there was some variation in the number of spores bound at each protein concentration when compared with collagen I and laminin (data not shown). The eVect of spore concentration on the adherence of spores to a fixed concentration of A549 cells is shown in fig 2 where again a dose-dependent relationship is seen. Using BSA as a control, it was previously shown that this binding was specific. 25 It had been reported that incubation of A549 epithelial cells with AfD had an eVect on the viability of the cells which was decreased to about 37% (95% CI 32 to 44) after treatment with 100% AfD for 48 hours. 25 In all the experiments incubation was for three hours and the cell viability was more than 90% as shown by trypan blue exclusion.
EFFECT OF AFD ON SPORE BINDING TO EXTRACELLULAR MATRIX PROTEINS AND A549 EPITHELIAL CELLS
AfD significantly enhanced spore binding to A549 cells at both concentrations used (p<0.002; fig 3) . After pre-incubation of the cells with 100% AfD the number of bound spores was enhanced by about 250% (95% CI 261 to 292). A control using a diVusate from A nidulans did not show significant enhancement of spore binding to A549 cells (data not shown). A significant enhancement was also seen in spore binding to laminin of 137% (95% CI 172 to 221), p<0.005, but not to fibrinogen. A similar enhancement eVect of AfD (data not shown) was seen for collagen I (p<0.005) and for fibronectin (p<0.002). fumigatus bind to ECM proteins and to A549 epithelial cells. The eVects of the spore surface diVusate AfD have also been widely reported. 16 19-22 25 What has not been investigated previously are the possible eVects of components of AfD, which are rapidly released into aqueous solution from the spore surface, on spore adhesion and their persistence in the lung. Clearly, the lung surface is an aqueous environment and it was thought that AfD may influence spore binding and interfere with spore clearance mechanisms. Our results show that AfD enhances spore binding to ECM proteins, fibrinogen, and to A549 epithelial cells. The mechanism of enhancement remains to be elucidated and we are currently attempting to purify the component(s) of AfD involved. This enhancement may provide a mechanism by which the residence time of the spore in the lung is increased and, together with the known immunosuppresive eVects of AfD, 16 19-22 25 the chances of germination and infection are thus increased. The in vivo significance of this enhancement needs to be determined as the amount of AfD used in these experiments is far greater than would be encountered in the lung. However, it is only necessary for a single spore to evade clearance to potentially cause infection. This interaction clearly requires further study.
Lung surfactant proteins SP-A and SP-D have an important role to play in lung defence mechanisms and bind directly to A fumigatus spores. 12 26 Our results show that, when rat lung lavage fluid enriched with SP-D was preincubated with ECM proteins, fibrinogen and A549 cells, spore binding was decreased significantly. It is not clear which component of SP-D enriched BAL fluid is responsible for the decrease in spore binding but it has been suggested that it may be SP-D since the inhibition is enhanced by the addition of calcium and it has already been reported that binding of both SP-A and SP-D to conidia was enhanced by calcium. 12 This fits in well with its known role in enhancement of spore clearance and its general protective role in the lung. The data presented here suggest a complicated interaction and potential competition between components of AfD and lung surfactant, the outcome of which may or may not result in A fumigatus infection. Research will continue on two fronts-to fractionate the AfD to identify the enhancer of spore binding and to study the interaction of purified SP-D with ECM proteins and A549 cells. 
